Elias K. Halvas

2.7k citations

31 papers · 1.2k indexed · h-index 15

Virology top 0.5%
- HIV Research and Treatment 28
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 24
- HIV/AIDS Research and Interventions 14
- Viral gastroenteritis research and epidemiology 1
Immunology
- Immune Cell Function and Interaction 3
Transplantation
Hepatology
Epidemiology
- Cytomegalovirus and herpesvirus research 5
Molecular Biology
- CRISPR and Genetic Engineering 2
- Biochemical and Molecular Research 2

Co-authors: John W. Mellors Mary F. Kearney John M. Coffin Sarah Palmer Judith Falloon Richard T. Davey Julia A. Metcalf Frank Maldarelli
Cited by: Virology Infectious Diseases Immunology
Journals: Proceedings of the National Academy of Sciences (3 papers)Journal of Clinical Investigation (2 papers)Clinical Infectious Diseases (1 paper)
Partner nations: United States South Africa Kenya

In The Last Decade

Elias K. Halvas

31 papers receiving 1.2k citations

Peers

Countries citing papers authored by Elias K. Halvas

Since Specialization

Citations

This map shows the geographic impact of Elias K. Halvas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elias K. Halvas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elias K. Halvas more than expected).

Fields of papers citing papers by Elias K. Halvas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elias K. Halvas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elias K. Halvas. The network helps show where Elias K. Halvas may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Elias K. Halvas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elias K. Halvas Line = papers co-authored together Elias K. Halvas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	HIV-1–infected T cell clones are shared across cerebrospinal fluid and blood during ART JCI Insight ·Meng Wang,Jennifer Yoon,Hailey Reisert,Bibhuprasad Das,Benjamin Orlinick,Jennifer Chiarella,Elias K. Halvas,John W. Mellors,Alina P.S. Pang,Lydia Barakat,Margaret Fikrig,Joshua C. Cyktor,Yuval Kluger,Serena Spudich,Michael J. Corley,Shelli Farhadian	2024	4
2	HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA Proceedings of the National Academy of Sciences ·Adam A. Capoferri,Ann Wiegand,Feiyu Hong,Jana L. Jacobs,Jonathan Spindler,Andrew Musick,Michael J. Bale,Wei Shao,Michele D. Sobolewski,Anthony R. Cillo,Brian T. Luke,Christine M. Fennessey,Robert J. Gorelick,Rebecca Hoh,Elias K. Halvas,Steven G. Deeks,John M. Coffin,John W. Mellors,Mary F. Kearney	2024	3
3	HIV infected CD4+ T cell clones are more stable than uninfected clones during long-term antiretroviral therapy PLoS Pathogens ·Shuang Guo,Brian T. Luke,Amy R. Henry,Samuel Darko,Leah D. Brandt,Ling Su,David Sun,Daria Wells,Kevin W. Joseph,Dimiter Demirov,Elias K. Halvas,Daniel C. Douek,Xiaolin Wu,John W. Mellors,Stephen H. Hughes	2022	5
4	Deep Sequencing Analysis of Individual HIV-1 Proviruses Reveals Frequent Asymmetric Long Terminal Repeats Journal of Virology ·Kevin W. Joseph,Elias K. Halvas,Leah D. Brandt,Sean C. Patro,Jason W. Rausch,Abha Chopra,S. Mallal,Mary F. Kearney,John M. Coffin,John W. Mellors	2022	10
5	Tracking HIV-1-Infected Cell Clones Using Integration Site-Specific qPCR Viruses ·Leah D. Brandt,Shuang Guo,Kevin W. Joseph,Jana L. Jacobs,Asma Naqvi,John M. Coffin,Mary F. Kearney,Elias K. Halvas,Xiaolin Wu,Stephen H. Hughes,John W. Mellors	2021	10
6	Insertional activation of STAT3 and LCK by HIV-1 proviruses in T cell lymphomas Science Advances ·John W. Mellors,Shuang Guo,Asma Naqvi,Leah D. Brandt,Ling Su,Zhonghe Sun,Kevin W. Joseph,Dimiter Demirov,Elias K. Halvas,Donna Butcher,Beth Scott,Aaron T. Hamilton,Marintha Heil,Baktiar Karim,Xiaolin Wu,Stephen H. Hughes	2021	24
7	Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in Children mBio ·Michael J. Bale,Mary Grace Katusiime,Daria Wells,Xiaolin Wu,Jonathan Spindler,Elias K. Halvas,Joshua C. Cyktor,Ann Wiegand,Wei Shao,Mark F. Cotton,Stephen H. Hughes,John W. Mellors,John M. Coffin,Gert U. van Zyl,Mary F. Kearney	2021	9
8	HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus Journal of Clinical Investigation ·Elias K. Halvas,Kevin W. Joseph,Leah D. Brandt,Shuang Guo,Michele D. Sobolewski,Jana L. Jacobs,Camille Tumiotto,John Bui,Joshua C. Cyktor,Brandon F. Keele,Gene D. Morse,Michael J. Bale,Wei Shao,Mary F. Kearney,John M. Coffin,Jason W. Rausch,Xiaolin Wu,Stephen H. Hughes,John W. Mellors	2020	87
9	Linked dual-class HIV resistance mutations are associated with treatment failure JCI Insight ·Valerie F. Boltz,Wei Shao,Michael J. Bale,Elias K. Halvas,Brian T. Luke,James McIntyre,Robert T. Schooley,Shahin Lockman,Judith S. Currier,Fred Sawe,Evelyn Hogg,Michael D. Hughes,Mary F. Kearney,John M. Coffin,John W. Mellors	2019	13
10	Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms Frontiers in Microbiology ·Jana L. Jacobs,Elias K. Halvas,Melissa A. Tosiano,John W. Mellors	2019	33
11	Intact HIV Proviruses Persist in Children 7-9 Years after Initiation of ART in the First Year of Life SSRN Electronic Journal ·Mary Grace Katusiime,Elias K. Halvas,Imogen A. Wright,Kevin W. Joseph,Michael J. Bale,Bronwyn Kirby-McCullough,Susan Engelbrecht,Wei Shao,Wei Hu,Mark F. Cotton,John W. Mellors,Mary F. Kearney,Gert U. van Zyl	2019	1
12	A9 A method to obtain full-length HIV proviral sequences and their sites of integration Virus Evolution ·Sean C. Patro,Xiaolin Wu,Shuang Guo,Michael J. Bale,Ann Wiegand,Jonathan Spindler,Christine M. Fennessey,Elias K. Halvas,Brandon F. Keele,Stephen H. Hughes,John W. Mellors,John M. Coffin,Jason W. Rausch,Mary F. Kearney	2019	1
13	No evidence of HIV replication in children on antiretroviral therapy Journal of Clinical Investigation ·Gert U. van Zyl,Mary Grace Katusiime,Ann Wiegand,William R. McManus,Michael J. Bale,Elias K. Halvas,Brian T. Luke,Valerie F. Boltz,Jonathan Spindler,Barbara Laughton,Susan Engelbrecht,John M. Coffin,Mark F. Cotton,Wei Shao,John W. Mellors,Mary F. Kearney	2017	55
14	Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells PLoS Pathogens ·John Bui,Elias K. Halvas,Elizabeth Fyne,Michele D. Sobolewski,Dianna Koontz,Wei Shao,Brian T. Luke,Feiyu Hong,Mary F. Kearney,John W. Mellors	2017	36
15	Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes Journal of Virological Methods ·Carole L. Wallis,Raquel Viana,Shanmugam Saravanan,Carlos Silva de Jesus,Clement Zeh,Elias K. Halvas,John W. Mellors	2016	2
16	Greater Suppression of Nevirapine Resistance With 21- vs 7-Day Antiretroviral Regimens After Intrapartum Single-Dose Nevirapine for Prevention of Mother-to-Child Transmission of HIV Clinical Infectious Diseases ·D. K. McMahon,Lei Zheng,Jane Hitti,Edwin SY Chan,Elias K. Halvas,Feiyu Hong,Joseph Kabanda,Frank Taulo,N. Kumarasamy,Julie Bonhomme,Carole L. Wallis,Karin L. Klingman,Michael D. Hughes,J. W. Mellors	2013	9
17	Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine Proceedings of the National Academy of Sciences ·Valerie F. Boltz,Yu Zheng,Shahin Lockman,Feiyu Hong,Elias K. Halvas,James McIntyre,Judith S. Currier,Margret C. Chibowa,Cecelia Kanyama,Apsara Nair,Willis D. Owino‐Ong'or,Michael D. Hughes,John M. Coffin,John W. Mellors	2011	47
18	Low Frequency Nonnucleoside Reverse‐Transcriptase Inhibitor–Resistant Variants Contribute to Failure of Efavirenz‐Containing Regimens in Treatment‐Experienced Patients The Journal of Infectious Diseases ·Elias K. Halvas,Ann Wiegand,Valerie F. Boltz,Mary F. Kearney,Dwight V. Nissley,Michael Wantman,Scott M. Hammer,Sarah Palmer,Florin Vaida,John M. Coffin,John W. Mellors	2010	81
19	Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy AIDS ·Sarah Palmer,Valerie F. Boltz,Frank Maldarelli,Mary F. Kearney,Elias K. Halvas,Diane Rock,Judith Falloon,Richard T. Davey,Robin Dewar,Julia A. Metcalf,John W. Mellors,John M. Coffin	2006	81
20	Wild-Type and YMDD Mutant Murine Leukemia Virus Reverse Transcriptases Are Resistant to 2′,3′-Dideoxy-3′-Thiacytidine Journal of Virology ·Elias K. Halvas,Evguenia S. Svarovskaia,Eric O. Freed,Vinay K. Pathak	2000	16

About Elias K. Halvas

Elias K. Halvas is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (24 papers), HIV/AIDS Research and Interventions (14 papers), Cytomegalovirus and herpesvirus research (5 papers), Immune Cell Function and Interaction (3 papers), CRISPR and Genetic Engineering (2 papers), Biochemical and Molecular Research (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). The work is most often cited by research in Virology (998 citations), Infectious Diseases (850 citations) and Immunology (169 citations). Elias K. Halvas has collaborated with scholars based in United States, South Africa and Kenya. Frequent co-authors include John W. Mellors, Mary F. Kearney, John M. Coffin, Sarah Palmer, Judith Falloon, Richard T. Davey, Julia A. Metcalf, Frank Maldarelli, Robin Dewar and Scott Hammer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact